California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant.
Mindstate Design Labs, backed by Silicon Valley power players, has created what its CEO calls “the least psychedelic psychedelic that’s psychoactive.”
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.
Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialogue with the FDA—but acknowledged recent setbacks.
The brain implant company cofounded by Elon Musk filed to trademark the product names Telepathy and Telekinesis. But it turns out that another person had already filed to trademark those names.
A new policy document outlines China’s plan to create an internationally competitive BCI industry within five years, and proposes developing devices for both health and consumer uses.
Scientists recorded in 3D and in real time the exact moment a human embryo implanted itself in an artificial uterus, opening new avenues for treating infertility.
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.
Scientists hope their plumage project could someday lead to biocompatible lasers that could safely be embedded in the human body.
On this episode of Uncanny Valley, we dive into the heated race between two companies to build a commercial brain-computer interface.
